News
Subscribe to get the latest investor, clinical and R&D news:
Press Releases and News Articles
June 2022: Gradalis Appoints Steven Engle as Chief Executive Officer
April 2020: Frontline Maintenance Vigil Immunotherapy Improves RFS in Ovarian Cancer
June 2019: Telemedicine: Catalyzing Cancer Care with Virtual Visits with Dr. Pete Anderson
March 2019: Gradalis Announces Medical Leadership Team Promotion
March 2019: Gradalis® Announces Initiation of Phase 3 Study of Vigil™ in Ewing’s sarcoma